(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BRIXADI

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

BRIXADI

ST13

US500000097523610

Class

5

Filing

97523610

Registration

7203579

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

23

Latest update

09/03/2025

Trademark type

Combined

Nice classes

5

Filing date

07/28/2022

Registration date

10/24/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/24/2023

Last transaction

09/03/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

07/12/2023

First use in commerce

07/12/2023

Drawing code

3

Owner type

03

Owner location

Plymouth Meeting, PA

Examiner

LORENZO, GEORGE

Law office

L10

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized word "Brixadi" with a small triangle and a large triangle appearing above and to the right of the word.

Holders and representatives

Holders

Braeburn, Inc.

Representatives

Sara M. Bauer Womble Bond Dickinson (US) LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of chemical addictions; injectable pharmaceuticals for the treatment of chemical addictions; pharmaceutical preparations for the treatment of opiate addictions; injectable pharmaceuticals for the treatment of opiate addictions; pharmaceuticals for the management and relief of pain; injectable pharmaceuticals for the management and relief of pain

Publications

History of USPTO decisions and trademark events.

23 publications found

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

09/02/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/24/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

10/24/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/03/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/03/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/03/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/03/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/03/2023

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

09/21/2023

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

09/20/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

09/01/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/30/2023

IUAF

USE AMENDMENT FILED

08/23/2023

EISU

TEAS STATEMENT OF USE RECEIVED

08/23/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

08/22/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/27/2023

PUBO

PUBLISHED FOR OPPOSITION

06/27/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/07/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/19/2023

DOCK

ASSIGNED TO EXAMINER

05/16/2023

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

08/23/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/20/2022

NWAP

NEW APPLICATION ENTERED

08/01/2022

Continuous trademark protection

Get notified about every new filing that threatens BRIXADI or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.